Patient Care

Calibrating CAR T-cell activation may improve response in solid tumors

03.30.23

Calibrating CAR T-cell activation may improve response in solid tumors

by

BT improves CD19 CAR-T patient outcomes in LBCL

03.28.23

BT improves CD19 CAR-T patient outcomes in LBCL

by ASTCT Science Highlights

DLL3 CAR T appears promising for SCLC treatment

03.21.23

DLL3 CAR T appears promising for SCLC treatment

by ASTCT Science Highlights

CV1 secreted by OrexiCAR T-cells reverses immunosuppression of myelomonocytoid cells

03.16.23

CV1 secreted by OrexiCAR T-cells reverses immunosuppression of myelomonocytoid cells

by ASTCT Science Highlights

Comorbidity index predicts CAR-T outcomes for DLBCL patients

03.13.23

Comorbidity index predicts CAR-T outcomes for DLBCL patients

by ASTCT Science Highlights

Bridging Radiation Therapy “May Reduce Predictors of Poor Post-CAR T Therapy Outcomes”

03.08.23

Bridging Radiation Therapy “May Reduce Predictors of Poor Post-CAR T Therapy Outcomes”

by Eleanor Mayfield, ELS

Second-Line Liso-Cel Significantly Improves EFS in LBCL in TRANSFORM Trial

03.03.23

Second-Line Liso-Cel Significantly Improves EFS in LBCL in TRANSFORM Trial

by Eleanor Mayfield, ELS

$Tisa-cel therapy for patients with refractory B-ALL$

02.14.23

Tisa-cel therapy for patients with refractory B-ALL

by ASTCT Science Highlights

Anti-PD-L1 scFv from CAR5-T cells may boost CAR-T antitumor efficiency

02.07.23

Anti-PD-L1 scFv from CAR5-T cells may boost CAR-T antitumor efficiency

by ASTCT Science Highlights

THANK YOU TO OUR SPONSORS

Jansen Oncology

Legend Biotech